BRLIZIO
Live / Applied — First extension granted (statement of use) (as of 12 Feb 2026)
What this means for you
Not registered yet, but its 26 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98874008
- Mark type
- Design + words
- Filed
- 26 Nov 2024
- Published for opposition
- 18 Nov 2025
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of CNS disorders.
Owner
- Lipocine, Inc., Salt Lake City, UT, US
- Lipocine, Inc., Salt Lake City, UT, US
Prosecution history
- 13 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2026 — SOU EXTENSION 1 GRANTED
- 12 Feb 2026 — SOU EXTENSION 1 FILED
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jul 2025 — NON-FINAL ACTION E-MAILED
- 23 Jul 2025 — NON-FINAL ACTION WRITTEN